Literature DB >> 32376612

Shared Ventilation in the Era of COVID-19: A Theoretical Consideration of the Dangers and Potential Solutions.

Jacob Herrmann1,2, Andrea Fonseca da Cruz3, Monica L Hawley2, Richard D Branson4, David W Kaczka5,6.   

Abstract

BACKGROUND: The use of shared ventilation, or the simultaneous support of multiple patients connected in parallel to a single mechanical ventilator, is receiving considerable interest for addressing the severe shortage of mechanical ventilators available during the novel coronavirus pandemic (COVID-19). In this paper we highlight the potentially disastrous consequences of naïve shared ventilation, in which patients are simply connected in parallel to a ventilator without any regard to their individual ventilatory requirements. We then examine possible approaches for individualization of mechanical ventilation, using modifications to the breathing circuit that may enable tuning of individual tidal volumes and driving pressures during either volume-controlled ventilation (VCV) or pressure-controlled ventilation (PCV).
METHODS: Breathing circuit modifications included a PEEP valve on each expiratory limb for both VCV and PCV, an adjustable constriction and one-way valve on the inspiratory limb for VCV, and a pressure-relief valve for peak inspiratory pressure reduction on the inspiratory limb for PCV. The ability to regulate individual tidal volumes using these breathing circuit modifications was tested both theoretically in computer simulations as well as experimentally in mechanical test lungs.
RESULTS: In both the simulations and experimental measurements, naïve shared ventilation resulted in large imbalances across individual tidal volume delivery, dependent on imbalances across patient mechanical properties. The proposed breathing circuit modifications for shared VCV and shared PCV enabled optimization of tidal volume distributions. Individual tidal volume for one patient during shared VCV was sensitive to changes in the mechanical properties of other patients. By contrast, shared PCV enabled independent control of individual patient-received ventilation.
CONCLUSIONS: Of the shared ventilation strategies considered, shared PCV, with the inclusion of in-line pressure-relief valves in the individual inspiratory and expiratory limbs, offers the greatest degree of safety and lowest risk of catastrophic mechanical interactions between multiple patients connected to a single ventilator.
Copyright © 2020 by Daedalus Enterprises.

Entities:  

Keywords:  COVID-19; coronavirus; differential lung ventilation; mechanical ventilation; shared ventilation; surge capacity

Mesh:

Year:  2020        PMID: 32376612     DOI: 10.4187/respcare.07919

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  9 in total

1.  PEEP/ FIO2 ARDSNet Scale Grouping of a Single Ventilator for Two Patients: Modeling Tidal Volume Response.

Authors:  Vitaly O Kheyfets; Steven R Lammers; Jennifer Wagner; Karsten Bartels; Jerome Piccoli; Bradford J Smith
Journal:  Respir Care       Date:  2020-08       Impact factor: 2.258

2.  Inpatient Mortality According to Level of Respiratory Support Received for Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Infection: A Prospective Multicenter Study.

Authors:  Alberto Palazzuoli; Franco Ruberto; Gaetano M De Ferrari; Giovanni Forleo; Gioel G Secco; Gaetano M Ruocco; Fabrizio D'Ascenzo; Francesco Mojoli; Silvia Monticone; Anita Paggi; Marco Vicenzi; Silvia Corcione; Anna G Palazzo; Maurizio Landolina; Erika Taravelli; Guido Tavazzi; Francesco Blasi; Massimo Mancone; Lucia I Birtolo; Francesco Alessandri; Fabio Infusino; Francesco Pugliese; Francesco Fedele; Francesco Giuseppe De Rosa; Michael Emmett; Jeffrey M Schussler; Peter A McCullough; Kristen M Tecson
Journal:  Crit Care Explor       Date:  2020-09-18

3.  Ventilatory Support in Patients with COVID-19.

Authors:  Paolo Maria Leone; Matteo Siciliano; Jacopo Simonetti; Angelena Lopez; Tanzira Zaman; Francesco Varone; Luca Richeldi
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Computational simulation to assess patient safety of uncompensated COVID-19 two-patient ventilator sharing using the Pulse Physiology Engine.

Authors:  Jeffrey B Webb; Aaron Bray; Philip K Asare; Rachel B Clipp; Yatin B Mehta; Sudheer Penupolu; Aalpen A Patel; S Mark Poler
Journal:  PLoS One       Date:  2020-11-25       Impact factor: 3.240

5.  Simultaneous ventilation in the Covid-19 pandemic. A bench study.

Authors:  Claude Guérin; Martin Cour; Neven Stevic; Florian Degivry; Erwan L'Her; Bruno Louis; Laurent Argaud
Journal:  PLoS One       Date:  2021-01-19       Impact factor: 3.240

6.  A New Medical Device to Provide Independent Ventilation to Two Subjects Using a Single Ventilator: Evaluation in Lung-Healthy Pigs.

Authors:  Ignacio Lugones; Roberto Orofino Giambastiani; Oscar Robledo; Martín Marcos; Javier Mouly; Agustín Gallo; Verónica Laulhé; María Fernanda Biancolini
Journal:  Anesthesiol Res Pract       Date:  2020-12-30

7.  Exhalatory dynamic interactions between patients connected to a shared ventilation device.

Authors:  Pedro M Garcia Eijo; Juan D'Adamo; Arturo Bianchetti; Thomas Duriez; Juan M Cabaleiro; Célica Irrazabal; Pablo Otero; Guillermo Artana
Journal:  PLoS One       Date:  2021-05-04       Impact factor: 3.240

8.  Use of a novel "Split" ventilation system in bench and porcine modeling of acute respiratory distress syndrome.

Authors:  Pierce Geoghegan; Jennifer Clarke; Grace Hogan; Aoife Keogh; Hannah Marsh; Karen Donnelly; Natalie McEvoy; Aoife Doolan; Stephen F Madden; Ignacio Martin-Loeches; Michael Power; John G Laffey; Gerard F Curley
Journal:  Physiol Rep       Date:  2022-09

9.  Performance of EasyBreath Decathlon Snorkeling mask for delivering continuous positive airway pressure.

Authors:  Alberto Noto; Claudia Crimi; Andrea Cortegiani; Massimiliano Giardina; Filippo Benedetto; Pietro Princi; Annalisa Carlucci; Lorenzo Appendini; Cesare Gregoretti
Journal:  Sci Rep       Date:  2021-03-10       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.